本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Benitec Biopharma Limited

13.59
-0.0900-0.66%
成交量:8.70万
成交额:119.35万
市值:3.46亿
市盈率:-7.02
高:14.12
开:13.55
低:13.20
收:13.68
数据加载中...
2020/10/07

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/06

重要事件披露

8-K - Current report
2020/10/01

SEC问询函

CORRESP [Cover] - Correspondence
2020/10/01

SEC问询函

CORRESP [Cover] - Correspondence
2020/10/01

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/09/23

重要事件披露

8-K - Current report
2020/09/23

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/08/19

重要事件披露

8-K/A [Amend] - Current report
2020/08/18

重要事件披露

8-K - Current report
2020/08/14

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2020/06/05

重要事件披露

8-K - Current report
2020/04/15

员工持股计划

Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/04/03

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]